Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

Adoptive immunotherapy with T cells expressing a tumor-specific chimeric T-cell receptor is a promising approach to cancer therapy that has not previously been explored for the treatment of lymphoma in human subjects. We report the results of a proof-of-concept clinical trial in which patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Till, Brian G., Jensen, Michael C., Wang, Jinjuan, Chen, Eric Y., Wood, Brent L., Greisman, Harvey A., Qian, Xiaojun, James, Scott E., Raubitschek, Andrew, Forman, Stephen J., Gopal, Ajay K., Pagel, John M., Lindgren, Catherine G., Greenberg, Philip D., Riddell, Stanley R., Press, Oliver W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2008
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2532803/
https://ncbi.nlm.nih.gov/pubmed/18509084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-12-128843
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados